Search research articles
Contact Us
Filters
Showing results (21-30 of 265) with videos related to
Page
of 27
Sort By:
Current Opinion in Molecular Therapeutics
|
January 27, 2009
Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders
Leigh D Church, Michael F McDermott
Cancer Chemotherapy and Biological Response Modifiers
|
September 2, 2004
Molecular predictors of prognosis and response to therapy in colorectal cancer
Howard L McLeod, Robert D Church
Journal of Clinical Microbiology
|
June 1, 1996
Extended incubation of culture plates improves recovery of Bordetella spp
G Katzko, M Hofmeister, D Church
Disease Models & Mechanisms
|
February 18, 2011
Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity
Roger D Cox, Christopher D Church
Expert Review of Clinical Immunology
|
October 29, 2010
Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes
Leigh D Church, Michael F McDermott
Therapeutic Innovation & Regulatory Science
|
January 12, 2020
Graduate Training Capacity for Regulatory Professionals at US Universities: Are We Facing a Talent Crisis?
Frances J Richmond, Terry D Church
Nursing
|
January 24, 2025
From expert to novice: Transitioning from clinician to faculty
Julie A Harding, Cory D Church
Journal for Nurses in Professional Development
|
May 29, 2019
Accreditation of Transition to Practice Programs: Assessing the Value and Impact
Cory D Church, Sheri Cosme, Morgan O'Brien
Nurse Educator
|
October 26, 2019
Helping Students Identify a Healthy Transition-to-Practice Work Environment
Cory D Church, Meagan White, Sheri Cosme
Journal of Continuing Education in Nursing
|
September 27, 2018
Factors Influencing Organizational Commitment and Turnover in Nurse Residents
Cory D Church, Zhaomin He, Susan Yarbrough
Page
of 27
Search research articles
Search
Showing results (21-30 of 265) with videos related to
Sort By:
Page
of 27
Current Opinion in Molecular Therapeutics
|
January 27, 2009
Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders
Leigh D Church, Michael F McDermott
Cancer Chemotherapy and Biological Response Modifiers
|
September 2, 2004
Molecular predictors of prognosis and response to therapy in colorectal cancer
Howard L McLeod, Robert D Church
Journal of Clinical Microbiology
|
June 1, 1996
Extended incubation of culture plates improves recovery of Bordetella spp
G Katzko, M Hofmeister, D Church
Disease Models & Mechanisms
|
February 18, 2011
Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity
Roger D Cox, Christopher D Church
Expert Review of Clinical Immunology
|
October 29, 2010
Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes
Leigh D Church, Michael F McDermott
Therapeutic Innovation & Regulatory Science
|
January 12, 2020
Graduate Training Capacity for Regulatory Professionals at US Universities: Are We Facing a Talent Crisis?
Frances J Richmond, Terry D Church
Nursing
|
January 24, 2025
From expert to novice: Transitioning from clinician to faculty
Julie A Harding, Cory D Church
Journal for Nurses in Professional Development
|
May 29, 2019
Accreditation of Transition to Practice Programs: Assessing the Value and Impact
Cory D Church, Sheri Cosme, Morgan O'Brien
Nurse Educator
|
October 26, 2019
Helping Students Identify a Healthy Transition-to-Practice Work Environment
Cory D Church, Meagan White, Sheri Cosme
Journal of Continuing Education in Nursing
|
September 27, 2018
Factors Influencing Organizational Commitment and Turnover in Nurse Residents
Cory D Church, Zhaomin He, Susan Yarbrough
Page
of 27